Baylor Scott & White Research Institute will establish the Texas site of the Connect for Cancer Prevention StudyTM (Connect), a project of the National Cancer Institute (NCI), part of the National Institutes of Health. Nine healthcare systems plan to enroll 200,000 adults across the U.S.
Tag: Cancer Risk
Exercise boosts anti-cancer immunity and reduces inflammation in Lynch Syndrome patients
Regular and intense aerobic exercise may reduce the risk of colorectal cancer in patients with Lynch Syndrome (LS) by improving the immune system’s ability to detect and remove potentially harmful cells, according to researchers at
The University of Texas MD Anderson Cancer Center.
Short-Term Use of Immunosuppressants Not Linked to Cancer Risk
Relatively short-term use of immunosuppressant medications to control an inflammatory disease was not associated with an increased risk of later developing cancer, according to new research led by scientists at the University of Pittsburgh and Mass Eye and Ear, a member of the Mass General Brigham health care system, and published today in the journal BMJ Oncology.
Study: Blood stem cell diversity arises in embryonic development
All humans have a diverse set of blood stem cell types that help govern overall health. As people age, they tend to lose this diversity, increasing their risk for blood cancers, cardiovascular disease and all-causes death. Yale School of Medicine…
Pancreatic Cancer Risk Lower if Pancreatic Cysts Remain Stable for Five Years
Low-risk branch duct intraductal papillary mucinous neoplasms (IPMN) are the most common precancerous form of mucinous pancreatic cysts and once identified require regular surveillance imaging. But consensus is still forming around how long that watchful period should last.
Adhering to global health recommendations reduces cancer risk
People who adhere to global Cancer Prevention Recommendations are putting themselves at lower risk of developing the disease, new research confirms.
CHOP Researchers Identify Potential Genetic Variants Linked to Increased Cancer Risk in Children with Birth Defects
Researchers have identified several genetic variants associated with increased risk of cancer in children with non-chromosomal birth defects, such as congenital heart disease and defects of the central nervous system. While the risk of developing cancer is not as high as children with chromosomal birth defects, it is significantly higher than children with no birth defects at all, and the findings may provide a basis for early detection in these understudied patients.
Mayo Clinic expert calls for public health measures to improve diet, reduce cancer risk
A review article by Mayo Clinic researchers emphasizes that early onset colorectal cancer, defined as being diagnosed when younger than 50, continues to steadily increase in the U.S. and other higher income countries. This increase, along with a decline in later-onset cases due primarily to screening have shifted the median age at diagnosis from 72 years in the early 2000s to 66 years now.
Drug used to prevent miscarriage increases risk of cancer in offspring
Exposure in utero to a drug used to prevent miscarriage can lead to an increased risk of developing cancer, according to researchers at The University of Texas Health Science Center at Houston (UTHealth Houston).
Comparing African and European populations leads to breast cancer risk discovery
By comparing genetic data from European and African population groups, scientists at UChicago Medicine Comprehensive Cancer Center have identified seven new regions of the human genome that are associated with increased breast cancer risk. The findings were published in Nature Communications.
The Medical Minute: You got your mother’s blue eyes. Will you get her breast cancer, too?
Family traits can be a source of pride – and a source of worry. Fortunately, only 5% to 10% of all cancers can be linked to a genetic mutation passed on from your mom or dad. How can you gauge your genetic risk?
MD Anderson Research Highlights for August 25, 2021
The University of Texas MD Anderson Cancer Center’s Research Highlights provides a glimpse into recently published studies in basic, translational and clinical cancer research from MD Anderson experts. Current advances include clinical studies to investigate novel treatment strategies, a new understanding of cancer precursor lesions, identifying a calcium signaling receptor, characterizing nodal immune flair after immunotherapy, a community screening tool for BRCA testing and a new method for diagnosing Clostridioides difficile infections.
Higher mushroom consumption is associated with a lower risk of cancer
Higher mushroom consumption is associated with a lower risk of cancer, according to a new Penn State study.
Exploring Mutational Signatures Associated with Exposure to Carcinogenic Microplastic Compounds
According to the World Health Organization (WHO), plastic products and their chemical derivatives present in the environment present public health concerns, including elevated risk of cancer. Researchers from Rutgers Cancer Institute of New Jersey explored to what extent common components in microplastic pollutants cause DNA damage in human cells.
Rutgers Awarded $1.5 Million FEMA Grant to Support Volunteer Firefighter Cancer Research and Prevention
The Rutgers School of Public Health received a $1.5 Million Federal Emergency Management Agency grant to support volunteer firefighter cancer research.
Neural network can determine lung cancer severity
NIBIB-funded researchers at Stanford University have created an artificial neural network that analyzes lung CT scans to provide information about lung cancer severity that can guide treatment options.
Cancer researcher identifies new areas in human genomes linked to skin cancer risk
An Indiana University scientist has identified eight new genomic regions that increase a person’s risk for skin cancer.
Updated Genetic Screening Guidelines Published by National Comprehensive Cancer Network Feature Emerging Evidence on Personalized Medicine
NCCN Guidelines for Genetic/Familial Risk Assessment: Breast, Ovarian, and Pancreatic updated with new and expanded sections on risk assessment and management related to three major cancer types.